by Brian Straight | Oct 9, 2018 | Latest News
Akrotome CEO accepts invitation to be a reviewer for NCI Bridge Award applications. Dr. Brian Straight, President and CEO of Akrotome, has accepted an invitation to be a reviewer for the National Cancer Institute’s Bridge Award Program, which seeks to provide...
by Akrotome Imaging | Jun 19, 2017 | Latest News
May 15, 2017—Akrotome Co-Founder Dr. James Basilion attended the World Molecular Imaging Congress/National Cancer Institute workshop in Washington DC. The workshop included participants from FDA and the Centers for Medicare & Medicaid Services (CMS). Focused on...
by Akrotome Imaging | Jun 1, 2017 | Latest News
June 1, 2017. Akrotome Imaging announces the launch of its FIRE probe technology. FIRE (Fluorescent Image Resection Enhancement) is a family for quenched, activity-based (QAB) and quenched substrate-based (QSB) probes with unparalleled performance, precision, and...
by Akrotome Imaging | Jan 13, 2017 | Latest News
Akrotome receives grant for the commercialization of a topical probe for margin determination in skin cancers Akrotome Imaging has received a $1.77M SBIR Phase II grant to assist in the clinical translation of its FIRE™ probe for margin assessment in skin cancer. In...
